[PDF][PDF] Clinical trial for Parkinson's disease gets a green light in the US
J Takahashi - Cell Stem Cell, 2021 - cell.com
J Takahashi
Cell Stem Cell, 2021•cell.comCell-based therapy is expected as an alternative treatment for Parkinson's disease. In this
issue of Cell Stem Cell, two accompanying papers (Kim et al., 2021; Piao et al., 2021) report
the induction of clinically applicable dopaminergic neurons from human embryonic stem
cells and the results of pre-clinical study toward a clinical trial.
issue of Cell Stem Cell, two accompanying papers (Kim et al., 2021; Piao et al., 2021) report
the induction of clinically applicable dopaminergic neurons from human embryonic stem
cells and the results of pre-clinical study toward a clinical trial.
Summary
Cell-based therapy is expected as an alternative treatment for Parkinson's disease. In this issue of Cell Stem Cell, two accompanying papers (Kim et al., 2021; Piao et al., 2021) report the induction of clinically applicable dopaminergic neurons from human embryonic stem cells and the results of pre-clinical study toward a clinical trial.
cell.com